Eli Lilly just dropped $1 billion—plus a $300 million bonus if trials go well—on gene therapy firm Verve, aiming to spice up ...

Detailed price information for Verve Therapeutics Inc (VERV-Q) from The Globe and Mail including charting and trades.

Global shares are mostly higher and oil prices have slipped as investors await a decision on interest rates by the Federal ...

Wall Street remained steady as investors awaited the Federal Reserve's policy decision, while global markets reacted to ...